Purchase of Apheresis Spectra Optia machines with maintenance and consumables
A Contract Award Notice
by NHS WALES SHARED SERVICES PARTNERSHIP
- Source
- Find a Tender
- Type
- Contract (Goods)
- Duration
- not specified
- Value
- £400K
- Sector
- HEALTH
- Published
- 29 Dec 2022
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
Cardiff and Vale of Glamorgan:
1 buyer
1 supplier
- Terumo BCT Larne
Description
NHS Wales Shared Services Partnership who are hosted by Velindre NHS Trust acting on behalf of Cardiff and Vale University Local Health Board wish to inform the market that they intend to award a contract for the purchase of three Apheresis Spectra Optia machines with maintenance and consumables.
Total Quantity or Scope
The South Wales Blood and Marrow Transplant Programme (SWBMT) serves adults and children within the catchment area of mid, west and south Wales, comprising six of the seven Welsh Local Health Boards (LHBs), with a combined population of approximately 2.4 million and accounting for over three-quarters of the Welsh population. The Children’s oncology unit at the Children’s Hospital for Wales (CHfW) is the only unit in Wales that provides treatment for children with complex haematological conditions (such as sickle cell anaemia or treatments requiring cell collection for re-infusion post chemotherapy). The unit works closely in partnership with the adult haematology department as the services are small and the processes required to manage the paediatric conditions are carried out rarely. Therefore education, training and maintaining competence are dependent on working in partnership with the adult service. The three Spectra Optia machines required to carry out apheresis, cell collection or cell processing procedures in this speciality are now of an age where they require replacement. The machine carries out highly specialist processes so they have to be reliable and accurate. This notice is for the purchase of three Spectra Optia machines including maintenance for up to five years (after the one year warranty) and consumables.
Award Detail
1 | Terumo BCT (Larne)
|
Renewal Options
Up to five years for maintenance (after the one year warranty) and consumables.
CPV Codes
- 33140000 - Medical consumables
- 33194210 - Blood-transfusion devices
Indicators
- Options are available.
Legal Justification
The apheresis service at Cardiff and Vale UHB provides: 1. Donor apheresis (collection of haematopoietic progenitor cells [HPC, A] and peripheral blood mononuclear cells for immediate therapeutic use as well as a precursor for manufacture into chimaeric antigen receptor (CAR) T-cells) [MNC, A] 2. Therapeutic apheresis including plasma exchange and red blood cell exchange NICE Medical Technologies Guidance [MTG28], published the 2nd March 2016 and updated August 2020, concluded, inter alia, that the Spectra Optia is effective for managing red blood cell exchange in managing sickle cell disease and further noted that use of the Spectra Optia is likely to result in significant cost savings in most patients with sickle cell disease. NICE further noted that adopting the Spectra Optia is estimated to result in cost savings per person per year. As a result of this Guidance, NHSE has adopted the Spectra Optia system for its apheresis services. Given the need to perform both donor and therapeutic apheresis, It is imperative that the chosen platform is able to perform both functions effectively and efficiently. The Spectra Optia is the only system to have been reviewed and approved by NICE [MTG28] for therapeutic red cell exchange with resultant savings to the NHS. This is a service provided to the Health Board's patient population with sickle cell disease. In addition, the Paediatrics department requires the same equipment throughout the Health Board to align with Adult services ensuring standardised patient treatment and care along with staff training. Any change in equipment would mean that staff would require retraining and through the initial transition there is a greater risk of use error due to unfamiliarity. On the above basis, the Health Board is issuing this notice and applying a 10 day standstill period prior to award of the purchase of three machines and a contract for up to five years for maintenance (after the one year warranty) and consumables.
Other Information
** PREVIEW NOTICE, please check Find a Tender for full details. ** The value stated in this notice is the higher ceiling contract figure and may not be fully utilised as this will be dependent upon the volume of consumables ordered and maintenance years taken up. (WA Ref:127796)
Reference
- ocds-h6vhtk-039481
- FTS 036674-2022